From Sparse Constrained Optimization to Micro/Nano 3D Printing: East China University of Science and Technology Team Breaks Through High-Concentration Cell Coincidence Detection Challenge

In frontier biomedical fields such as single-cell analysis and immune monitoring, label-free microfluidic impedance sensing has become a core technology for single-cell counting and electrical phenotyping thanks to its precision and convenience. However, signal coincidence in high-concentration cell suspensions has long limited detection accuracy. When multiple cells enter the sensing region simultaneously, their signals overlap and distort, resulting in inaccurate counts and errors in electrical phenotype statistics.

A team from East China University of Science and Technology, in collaboration with Huashan Hospital affiliated with Fudan University, published the study A Sparse Constrained Optimization Method for Resolving Coincident Single-Cell Events in Microfluidic-Based Impedance Sensing in IEEE Transactions on Biomedical Engineering. The team proposed a two-step algorithmic framework based on sparse constrained optimization, enabling high-precision analysis of coincidence events in high-concentration cell suspensions and accurate extraction of single-cell impedance signals. The key microfluidic impedance cell-counting chip was precision-fabricated using the MP-100-6L micro/nano 3D printer from Shanghai Prismlab Technology Co., Ltd. ("Prismlab").

From Detection to De-Convolution: A Dual Breakthrough in Single-Cell Analysis

Impedance-based single-cell detection has been widely applied in cell sorting, electrical phenotyping, and cell-growth monitoring because it requires no fluorescent labeling or biochemical staining and supports real-time online monitoring. Yet when high-concentration cell suspensions pass through the detection area, "coincidence" events - in which two or more cells pass through the electrode sensing region simultaneously or nearly simultaneously - remain a core challenge in the field.

Coincidence events not only cause missed cell counts, but also distort impedance waveforms, leading to systematic bias in subsequent electrical phenotype statistics. Traditional thresholding and cross-correlation methods degrade sharply under high-concentration and low-signal-to-noise conditions. Existing solutions often rely on complex electrode-structure redesigns or dedicated coding schemes, creating tight coupling between algorithms and hardware and limiting adaptability.

The breakthrough of this study lies in an innovative combination of sparse optimization, dual dictionaries, and no hardware modification:

Sparse constrained optimization replacing traditional threshold detection: the research team modeled the passage of cells through the microfluidic chip as a sparse representation problem in a linear time-invariant system and introduced l1-norm regularization. Through global optimization rather than local threshold comparison, the method locates and segments cellular events. This sparsity-driven approach automatically suppresses low-contribution noise components to zero, fundamentally improving detection robustness.

Two-step expanded dictionary framework: first, a waveform-detection dictionary is constructed to extract cellular waveform locations and segment the signal through sparse optimization; second, a de-coincidence dictionary is built to perform sparse decomposition of the segmented signals using waveform templates at different flow velocities. The continuity of sparse coefficients is then used to identify coincidence levels accurately. By replacing one large dictionary with two smaller dictionaries, the method balances accuracy and computational efficiency.

No hardware modification required: unlike methods that rely on four-channel CDMA coding, hyperbolic electrode structures, Barker-code modulation, or other special chip structures, this algorithm operates with a standard three-coplanar-electrode configuration. By replacing the dictionary templates, it can adapt to different electrode configurations, effectively decoupling algorithm development from hardware design.

How Does Prismlab Micro/Nano 3D Printing Empower Advanced Microfluidic R&D?

Ultra-high precision for micron-scale channels: with 2-micron layer thickness and sub-pixel micro-scanning technology, three-dimensional microchannels can be formed with high accuracy. The 30 microns x 30 microns microchannel cross-section and 20-micron electrode spacing in the paper both rely on the high dimensional accuracy and surface smoothness of the printed mold, ensuring stable flow fields and reliable impedance signals.

Freedom of 3D structural fabrication beyond 2D limits: complex chip structures can be printed in a single step without multilayer bonding, significantly reducing assembly errors. The microchannels, inlets, and detection regions are integrally formed, avoiding cumulative alignment errors common in conventional soft lithography.

Mold-free rapid iteration, shortening R&D cycles from days to hours: from CAD design to chip-mold forming, the process takes only a few hours. No masks, photolithography, or repeated mold opening are required; researchers can design, print, and use the chip rapidly to optimize channel structures and electrode layouts.

Controlled cost and suitability for batch R&D: by balancing precision and cost, the technology provides a feasible path for microfluidic chips to move from laboratory prototypes toward scalable validation.

Domestic Micro/Nano 3D Printing Empowering Frontier Innovation

From precision forming of microchannels, to rapid fabrication of single-cell impedance detection chips, to intelligent analysis of cell coincidence events, Prismlab's micro/nano 3D printing technology is providing a solid foundation from design to validation for the integration of microfluidics with sparse signal processing and artificial intelligence.

In cell counting and electrical phenotyping, the technology enables rapid fabrication of high-precision impedance detection chips and supports label-free, high-throughput single-cell characterization, providing hardware support for tumor immunotherapy monitoring, hematology analysis, and microbial detection. In synthetic biology, it enables precise construction of microreactors and cell-culture chips, supporting high-throughput quantitative analysis of yeast and other microorganisms and guiding optimization of culture conditions and genetic circuits. In clinical diagnostics, it can provide miniaturized and integrated microfluidic chip prototypes for point-of-care testing (POCT) devices, accelerating diagnostic-tool development and iteration.

Localization, high precision, and high efficiency are more than Prismlab's technology labels; they represent a source of momentum for global scientific research and industrial innovation against the broader backdrop of China's high-end manufacturing upgrade.